Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term open-label perindopril study in hypertensive children previously treated with S 90652
2005-000474-42Phase 2Completed
- Sponsor
- Servier
- Start
- Oct 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of perindopril in hypertension (HTN) and essential hypertension, sponsored by Servier. Primary endpoints: Adverse events, Estimated glomerular filtration rate and 6 more. Started Oct 2007; status: completed.
02
Drugs
perindopril
03
Conditions
hypertension (HTN)essential hypertension
Beyond the preview
Go deeper on 2005-000474-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000474-42.